National health expenditure per capita is associated with CRT implantation practice: findings from the ESC CRT Survey II with 11 088 patients
CRT Survey II has demonstrated a non-uniform delivery of healthcare. Countries with low health expenditure per capita appear to be reserving CRT therapy for younger patients, those with class IA indication and patients with more severe symptoms of heart failure.
Authors
- Cecilia M. Linde (ORCID: https://orcid.org/0000-0002-9039-6023)
- Stelios I. Tsintzos (ORCID: https://orcid.org/0000-0001-9611-7120)
- Z. Ihara (ORCID: https://orcid.org/0000-0003-0613-0263)
- Nigussie Bogale (ORCID: https://orcid.org/0000-0002-2521-7551)
- Camilla Normand (ORCID: https://orcid.org/0000-0002-0978-3449)
- Kenneth Dickstein (ORCID: https://orcid.org/0000-0002-8131-1729)
Institutions
- Karolinska University Hospital (SE)
- Stavanger University Hospital (NO)
- Haukeland University Hospital (NO)
- Karolinska Institutet (SE)
- Abbott (Canada) (CA)
- Abbott (Belgium) (BE)
- Abiomed (United States) (US)
- University of Bergen (NO)
- University of Stavanger (NO)
Publication Details
- Journal
- European Heart Journal - Quality of Care and Clinical Outcomes
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1093/ehjqcco/qcae082
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Abbott Fund
- Bayer
- Boston Scientific Corporation
- Medtronic
- Biotronik
- Servier
- Bristol-Myers Squibb Canada